A. Rupérez

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

C. Font, A. M. Muñoz Martín, I. Ortega, 2018, British Journal of Cancer.

Evaluation of a Heredofamilial Cancer Unit in Increasing Family History Collection and Genetic Counseling Referrals Among Spanish Oncologists at a University Hospital

Miguel Martín, A. Rupérez, I. Márquez-Rodas, 2014, Journal of Genetic Counseling.

Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)

J. García-Foncillas, V. Moreno, A. Rupérez, 2019, Archives of Clinical and Medical Case Reports.

Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2.

A. Rupérez, P. Alfonso, M. Jiménez, 2016, Oncology letters.

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

C. Font, V. Pachón, V. Castellón, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive factors in metastasic colorectal cancer.

Miguel Martín, A. Rupérez, I. Gallego, 2018 .